Insider · SEC Form 4 · Director, See Remarks and Footnotes
BVF PARTNERS L P/IL
In the 12 months to Nov 8, 2026, on the open market: sold $173.7M of KYMR. Filed 0 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
- KYMRSold: Kymera Therapeutics, Inc. $173.7M
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.